Bispecifics Part 3: Pros and Cons of Bispecifics

In this video, IMF Chief Medical Officer Joseph Mikhael discusses the main benefits of bispecific antibody therapies, such as the ability to administer these drugs off the shelf, their mechanisms of action, and how they can recognize antigens on the surface of multiple myeloma, and more. He also points out the potential side effects of bispecific therapies.
_______________
Improving Lives | Finding the Cure
Founded in 1990, the International Myeloma Foundation (IMF) is the first and largest organization focusing specifically on multiple myeloma. The IMF’s reach extends to more than 525,000 members in 140 countries worldwide. The IMF is dedicated to improving the quality of lives of myeloma patients while working toward prevention and a cure through our four founding principles: Research, Education, Support, and Advocacy.
Subscribe to our channel: / imfmyeloma
Visit our website at: www.myeloma.org
Find us online:
Facebook: @myeloma | / myeloma
Twitter: @IMFMyeloma | / imfmyeloma
Instagram: @imfmyeloma | / imfmyeloma
LinkedIn: / international-myeloma-...
Support the IMF | Donate Now! secure.myeloma...
Category
Nonprofits & Activism
License
Standard TH-cam License
In most cases, captions are autogenerated by TH-cam.

[@dr.satyabratasahoo5644]

Good

[@pjrockturnal]

Great video series thank you so much for taking the time to do this

[@floradaniels9220]

Thank you n